Niederhuber John

CIK 00015012402 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001501240

Recent Transactions

42 trades

Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2026-08-06−400→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2026-08-06+400→ 400 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2025-08-06+7,200→ 7,200 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2025-07-17−1→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2025-07-17+1→ 1 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-07-17+925→ 925 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-06-02+81→ 217 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-06-02−81→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-06-01+7→ 136 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-06-01−7→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-08-09−3,571→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-08-09+3,571→ 5,682 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-06-02+3,571→ 3,571 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-06-01−297→ 298 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-06-01+297→ 2,111 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-08-09+3,571→ 3,571 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2022-06-01+298→ 1,814 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-06-01−298→ 595 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2021-06-01+893→ 893 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2021-06-01+2,678→ 2,678 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−1,339→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−892→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−1,785→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+1,322→ 1,322 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+170→ 170 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-02+3,571→ 3,571 total
Purchase
Aptevo Therapeutics Inc.$APVO
Common Stock
2019-06-14$0.91/sh+714→ 1,516 total
Award
Aptevo Therapeutics Inc.$APVO
Option (right to buy)
2019-06-01+25,000→ 25,000 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2018-06-01+25,000→ 25,000 total
Award
Aptevo Therapeutics Inc.$APVO
Employee Stock Option (right to buy)
2017-06-01+12,500→ 12,500 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2016-08-03+18,750→ 18,750 total
Disposition to Issuer
Emergent BioSolutions Inc.$EBS
Common Stock
2016-05-18−7,833→ 22,467 total
Disposition to Issuer
Emergent BioSolutions Inc.$EBS
Common Stock
2016-05-18−7,833→ 30,300 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2015-05-21+9,400→ 30,300 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2013-05-23+3,600→ 16,200 total
Award
Emergent BioSolutions Inc.$EBS
Director stock option (right to buy)
2013-05-23+7,200→ 7,200 total
Award
Emergent BioSolutions Inc.$EBS
Director Stock Option (Right to buy)
2012-05-17+7,200→ 7,200 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2012-05-17+3,600→ 12,600 total
Award
Emergent BioSolutions Inc.$EBS
Director Stock Option (right to buy)
2011-05-19+7,200→ 7,200 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2011-05-19+3,600→ 9,000 total
Award
Emergent BioSolutions Inc.$EBS
Director Stock Option (right to buy)
2010-08-23+10,800→ 10,800 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2010-08-23+5,400→ 5,400 total

Companies

Recent Filings

Address

2401 4TH AVENUE SUITE 1050

SEATTLE, WA, 98121

View on SEC.gov